C artilage lesions are common in the general and athletic populations [1] [2] [3] . Current algorithms rely on the size and location of the defect to direct treatment recommendations [4] [5] [6] [7] [8] . Specifically, cartilage lesion size may be an important factor in determining clinical outcomes 9, 10 . Preoperative magnetic resonance imaging (MRI) yields inaccurate estimates of lesion size and may overlook other defects in the knee [11] [12] [13] [14] . Cartilage defects often are larger than appreciated on MRI because of hidden delaminations or unstable cartilage flaps surrounding the defect. Therefore, the gold standard for sizing cartilage defects of the knee has been the direct measurement of defect size during arthroscopic knee surgery, commonly based on post-debridement arthroscopic sizing. Novel sizing methods, such as ultrasound examination, have been introduced as clinically feasible mechanisms for the diagnosis of cartilage lesions at the time of arthroscopy, but direct visual measurement still remains the gold standard 15 . *Samples from the trochlea had the largest defect areas, followed by the medial femoral condyle (MFC), the lateral femoral condyle (LFC), and the patella. The tibial defects were the smallest. ‡Excluding 1 outlier.
The reported accuracy of arthroscopic sizing of defects varies in the current literature 16 . Arthroscopic assessment was found to overestimate lesion size when compared with arthrotomy for the sizing of defects in 2 European studies 17, 18 . These studies comprised a total of 440 lesion measurements at the time of initial arthroscopic assessment using an arthroscopic probe and subsequent open measurement with a ruler at the time of arthrotomy. In contrast, a recent study found that arthroscopy generally underestimated the true size of defects based on a plastic mold of the lesion 19 . Furthermore, in that study, the size of the defect and the measurement device used affected the accuracy of measurement.
Limitations of the previous studies prevented conclusive application to clinical practice. All involved single measurements by surgeons with different ranges of experience, and various unmeasured factors may have influenced the accuracy of sizing and potentially biased the conclusions [17] [18] [19] . Additionally, these studies did not evaluate interrater or intrarater reliability. Current clinical trials often utilize a single sizing mechanism for measuring cartilage defects, and a better understanding of which sizing mechanism is most reproducible and accurate is needed 20, 21 . We evaluated the interrater and intrarater reliability of the sizing of cartilage defects using common arthroscopic measuring devices. Our hypothesis was that the interrater and intrarater reliability would be high.
Materials and Methods
T he experiments were performed on 10 fresh human cadaveric knee specimens from mid-femur to mid-tibia. No previous surgery had been performed on any of the knees. Knees were mounted to an arthroscopic leg holder. Through a 10-cm midline incision, a medial parapatellar incision was made. Through this incision, 5 discrete lesions were created in each knee, 1 in each of the following locations: the medial femoral condyle, the lateral femoral condyle, the medial tibial plateau, the trochlea, and the patella. An independent team made all of the study cartilage lesions. In each location, the lesions were randomly assigned a size and shape (circular, oval, or amorphous), such that lesion shapes and sizes were equally distributed among locations (tibial lesion size was limited due to anatomical limitations). Core punches of known size were used to make the initial defects, followed by the use of curets to complete full-thickness cartilage defects (International Cartilage Repair Society grade 3C). As previously established, a plastic mold (Friendly Plastic; AMACO) was created for each defect 19 . This mold represented our gold standard for accurate sizing of each defect, and no lesion debridement was performed by surgeons prior to lesion measurements. Molds then were painted black using permanent marker and subsequently scanned into a computer. Using commercially available software (Adobe Acrobat 7.0 Professional; Adobe Systems) the area of each gold-standard plastic mold was determined. All study knees were then closed in layers.
Three sports medicine fellowship-trained orthopaedic surgeons participated in this study. Each surgeon used a standard arthroscopic camera and irrigation system (Smith & Nephew). Four unique techniques were used to estimate cartilage defect area. First, each surgeon visually estimated the size of the defects through the arthroscopic camera, without the aid of mechanical instrumentation (referred to as visualization). This step was repeated for each knee in a random fashion (Latin square randomization), before measurements with instruments, such that surgeons were randomly assigned knees for measurement.
Surgeons then measured all defects in all 10 knees (50 defects per surgeon [5 defects per knee · 10 knees per surgeon]) with each measurement instrument (3 techniques) on separate occasions. This sequence was repeated a second time. In addition to visualization, the 3 measurement techniques used by the surgeons were as follows: use of a mechanical probe (Smith & Nephew) with a 3-mm hook perpendicular to the shaft of the tool and with lines along the shaft of the tool marked in 5-mm increments (3-mm probe), use of a simple metal ruler (Smith & Nephew) with millimeter demarcations (simple metal ruler), and use of a tool with a retractable and flexible end and markings every 2 mm (Arthrex) (sliding metallic ruler tool). A random pattern of knees and measurement tools was determined for each surgeon before investigation. Thus, no surgeon knew which technique they were to use or which knee they were to measure until measurement took place. Table I depicts the randomization process.
Each surgeon sized defects in single knees using each of the 3 measurement devices in random order, in an effort to prevent measurement bias between instruments. Surgeons reported defect size to a research team member in 1 of 3 ways: (1) reporting the area directly during visualization (e.g., "3 cm 2 "), (2) describing the shape and size of the defect, allowing for subsequent calculation of the area (e.g., "a circle with a 3-cm radius"), or (3) providing 2 measurement values that then were multiplied to determine the area (e.g., "2 cm by 1.5 cm"). Each surgeon, using each of the measuring techniques, measured all 10 knees once. The process was repeated, but with a different randomized knee and instrument order (Latin square randomization). Thus, each surgeon arthroscopically measured the defects in the knees on 4 separate occasions, including visualization measurement. The entire Table IV. 982
process was then repeated a second time, for an assessment of intrarater reliability, resulting in a total of 1,200 measurements.
Statistical Analysis
Our statistical objectives were to (1) assess the reliability and reproducibility of cartilage defect measurements and (2) assess systematic bias inherent in the 4 measurement methods. Repeated-measures data were analyzed using a mixed-effect linear model in which the 3 surgeons and 10 knees were treated as random effects and the gold-standard values for defect sizes were used as covariates. The differences between the observed and gold-standard values were used as the response (see Appendix). Statistical models were fitted for each anatomical location and measurement method separately, because variability for individual raters and between raters (variance component) differed with both of these factors. Prediction bias and 95% prediction limits were computed for the median goldstandard values using these models. Intraclass and interclass correlation coefficient (ICC) values for intrarater and interrater reliability were computed using the estimates of relevant variance components. Intraclass and interclass correlation is an assessment of the reproducibility of quantitative measurements of the same measure, made more than once by the same observer or made by different observers 22 . In addition, overall ICC values were calculated for all ratings using a separate statistical model (see Appendix). Spearman rank correlation analysis was used to evaluate the strength of the association between the gold-standard femoral measurements and the measurements of raters. Using pairs generated by each replicate of each rater for each method, correlations were computed for each measurement method. The 95% confidence interval (CI) for ICC and Spearman rank correlation values were computed using Fisher z-transforms of relevant correlation coefficients. Statistical analyses were carried out using JMP software (version 10; SAS Institute). A power analysis was not possible because of the nature of the study objectives and study design (interrater and intrarater reliability analysis involving multiple anatomical locations).
Results

F
ive lesions were successfully created in all 10 knees. Lesion size ranged from 0.36 to 6.02 cm 2 (mean, 2.369 cm 2 ) (Table II and Fig. 1) . Each surgeon performed 80 arthroscopies. A total of 1,200 data points were collected: 300 from visualization and 900 from sizing with the measurement instruments. Rater, location of lesion, and measurement *Median values represent the median defect size by location. Bias indicates the predicted mean difference between the estimate for the given measurement tool at the given anatomical location and the corresponding GS value. LFC = lateral femoral condyle, and MFC = medial femoral condyle.
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T 21, 2017 method all affected the cartilage defect measurements/ estimates. The overall intrarater and interrater reliability data are shown in Table III . Among all femoral lesions, the intrarater reliability (ICC, 0.7001) and the interrater reliability (ICC, 0.6170) were highest for the sliding metallic ruler tool. The intrarater reliability (ICC, 0.5067) and the interrater reliability (ICC, 0.3096) were lowest for the visualization method. According to the Altman guidelines, reliability of 0.0 to 0.20 = poor, >0.20 to 0.40 = fair, >0.40 to 0.60 = moderate, >0.60 to 0.80 = good, and >0.80 to 1.00 = very good 23 . On the basis of these guidelines, good reliability was demonstrated by the sliding metallic ruler tool for both values (intrarater and interrater). The visualization measurement method demonstrated moderate intrarater reliability and fair interrater reliability.
Tables IV and V present Spearman rho correlation coefficients for each measurement method. We assessed the association between the gold-standard femoral measurements and the measurements made by the raters using the different 
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measuring methods. The simple metal ruler method demonstrated the strongest correlation with the gold-standard measurements (median Spearman rho, 0.77), whereas the visualization method demonstrated the weakest correlation (median Spearman rho, 0.62). On the basis of the Cohen standards for evaluating correlation coefficients, high correlation (>0.50) existed between all measurement techniques and the gold standard 24 . Surgeons consistently underestimated lesion size, and the difference between gold-standard size and measured size was larger (more inaccurate) for larger gold-standard lesions compared with smaller gold-standard lesions (Tables VI and VII). Figure 2 shows the difference between gold-standard lesion size and all surgeon estimates and demonstrates the general trend of the undersizing of lesions as the gold-standard lesion size increased. In addition, bias (in cm 2 ) in relation to the gold standard among all surgeons for each anatomical location and measurement method is depicted in Figure 3 . When comparing estimates of lesion size with the gold standard, 60.5% of the surgeon measurements underestimated lesion size. The average difference between the gold standard and the surgeon estimate among all locations and all tools was 0.5253 cm 2 (range, 0.0239 to 1.1036 cm 2 ). When defects were underestimated, defect size influenced the amount of underestimation. Bias from true size tended to increase as lesion size increased.
Table VI presents the median lesion size among all 10 lesions at a particular location among the 10 knees (goldstandard median) and the average bias (among all surgeon estimates) from the gold standard at each location and for each tool. By location, measurements of tibial cartilage lesions *For the lateral femoral condyle (LFC) and the medial femoral condyle (MFC), the ICCs were similar for the 3-mm probe, the sliding metallic ruler, and the simple metal ruler. ICC values being close to 1 implies that raters are interchangeable. The best agreement was achieved for the MFC, and the lowest agreement was for the tibia.
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were closest to true size. The tibia also had the smallest created lesions, averaging 0.725 cm 2 (range, 0.36 to 1.08 cm 2 ). In contrast, measurements of lesions at the trochlear site were, on average, the farthest from true size. The trochlea had the largest created lesions, averaging 3.32 cm 2 (range, 1.40 to 5.19 cm 2 ). Visualization had the largest variation (standard deviation) between replicate measurements by the same rater (Table VII) . On analysis of measurement methods, use of the 3-mm probe resulted in lesion sizes that were farthest from true size (average of median biases for the 5 locations, 20.68 cm 2 ) and thus was most inaccurate (Table VI) . Visualization had the least average median bias (20.256 cm 2 ). Average median bias for the sliding metallic ruler tool was 20.462 cm 2 and for the simple metal ruler was 20.384 cm 2 .
The intrarater and interrater reliability was fair to good in most areas of the knee. The ICC values calculated for intraobserver and interobserver reliability showed distinct trends by location and measurement method (Table VIII) . The ICC values for both intrarater reliability (ICC-1, the level of agreement of repeated measurements by a single observer) and interrater reliability (ICC-2, the level of agreement between observers) were generally lowest for the measurement of lesions at the tibia. The highest ICC-1 and ICC-2 values (best correlation) occurred for the measurement of lesions at the medial and lateral femoral condyles. ICC-1 and ICC-2 values were higher for the sliding metallic ruler tool and the simple metal ruler for measurements made at the 2 condyles compared with the other locations. Overall, ICC-1 and ICC-2 values were best with the sliding metallic ruler tool. ICC-1 and ICC-2 values were slightly lower for the simple metal ruler and 3-mm probe compared with those for the sliding metallic ruler tool. Overall, visualization had the lowest reliability of all methods.
Discussion
S everal factors may influence arthroscopically obtained estimates of defect size: the lesion location, measurement tool, surgeon, and defect size itself. Most importantly, we found that intrarater and interrater reliability was fair to moderate for the evaluation of cartilage lesions using visualization only, but moderate to good when using a simple metal ruler, sliding metallic ruler tool, or 3-mm probe. In addition, the determination of lesion size was dependent on location, was less accurate as lesion size increased, and was dependent on the method of measurement. Finally, visualization of cartilage lesions demonstrated the weakest correlation with the gold-standard measurements, and the simple metal ruler demonstrated the strongest correlation. Thus, because cartilage treatment algorithms universally use lesion size as a branch criterion, the surgeon should measure with a probe or a graduated measurement device (simple metal ruler or sliding metallic ruler) to optimize reliability and correlation to gold-standard measurements.
Our findings have important implications. Algorithms for treatment choice often base decision points on the size and location of cartilage defects 4, 5 . Surgeons frequently rely on postdebridement arthroscopic measurement of defects, and a variety of methods are commonly used to estimate size. Despite new imaging modalities, many surgeons believe that use of measuring devices during arthroscopic surgery is necessary for achieving accurate lesion measurement 15, [25] [26] [27] . Our study is, to our knowledge, the first to evaluate the intrarater and interrater reliability of cartilage defect measurements. The intrarater and the interrater reliability were best for the measurement of femoral condylar lesions. Intrarater reliability was better than interrater reliability in the patellofemoral joint. The use of visualization demonstrated less reliability compared with use of a measuring tool. Use of a graduated measuring tool (simple metal ruler or sliding metallic ruler) had the best interclass coefficients in all areas of the knee except the patella, where a probe performed better. This information may be useful in the design of prospective and multicenter studies. Many studies use a 2-cm 2 cutoff to determine treatment choice 4 or use size as a method of evaluating study results [28] [29] [30] [31] [32] . Clinical studies should indicate a consistent method for measuring lesions to ensure minimal variation among measurement devices. Measurement tools have moderate to good reliability, and we found best reliability in the femoral condyles. A more appropriate and reliable instrument to measure patellofemoral defects is needed to improve the reproducibility of sizing.
Surgeons consistently underestimated defect size in our study, and the underestimation and variability increased as the size of the defect increased. The inaccuracy of arthroscopic measurements has been highlighted previously [17] [18] [19] . Two clinical studies showed an overestimation of sizing by arthroscopic probe with 4 or 5-mm increments at the time of arthroscopic surgery 17, 18 . These studies compared measurements of size with a gold standard using a ruler to measure defect size during the open procedure. In contrast, in a previous study using several devices, surgeons typically overestimated small lesions but underestimated larger lesions (>2 cm 2 ) 19 . In that study, surgeons performed single measurements with different measuring tools on 1 occasion for the same knee. This measurement then was compared with a plastic mold of the defect that accurately reflected the true size of the defect. Our study supports the finding that arthroscopic measurement underestimates the size of the defect, and if not considered, may bias treatment. Differences among previous clinical and laboratory studies and our laboratory study could arise from regional biases in sizing of defects or differences in study design, including the ability to mold the true size of the defect in laboratory studies.
Interestingly, lesion location influenced the surgeon's ability to accurately size a lesion. Lesions in the trochlea had the highest bias in measurement, as previously reported 19 . Variability in the contour of the trochlea 33, 34 makes manipulating instruments arthroscopically to obtain accurate measurement especially difficult and may explain this variation. In contrast, the sizing of patellar defects had the smallest variability. This difference could be due to the limited amount of curvature in comparison with the trochlea and femoral condyles, allowing for more precise anterior-posterior and medial-lateral measurement. Most importantly, this finding highlights the difficulty of cartilage defect measurements along curved surfaces with large defects.
All measurement tools underestimated the size of the defects, but the 3-mm probe had the highest measurement bias at all lesion locations. In contrast, the simple metal ruler and sliding metallic ruler tool more accurately measured defect size. These 2 devices also had the best intrarater and interrater reliability. Although visualization had lower bias, the interrater and intrarater reliability was fair to moderate overall, suggesting visualization may not be a reliable sizing method. Determining the best way to measure a defect is crucial because clinical studies use lesion size as an outcome determinant [28] [29] [30] [31] [32] . However, how accurate lesion measurement needs to be to impact treatment outcomes in patient care remains to be clarified. Nevertheless, on the basis of our findings, prospective studies may benefit from the use of a clearly line-marked measuring tool for measuring defects. Reporting of the measurement technique should be obligatory. In addition, when measurements are in "gray zones" of treatment algorithms, it may be prudent to remeasure cartilage lesions prior to making treatment decisions, given the clear possibility of inaccurate measurement.
We employed a randomization protocol for the evaluation of cartilage defects with various devices. Despite efforts to eliminate potential biases and allow broad application of results, our study had some limitations. First, the range of lesion size was limited in certain areas of the knee, specifically the patella and the tibia. All tibial lesions were created arthroscopically with a curet that limited possible sizes and shapes in the uncovered portion of the tibia (weight-bearing portion of the tibia not covered by the meniscus). Second, lesions of the patella had a limited range of sizes because of the limited surface area. However, this limited range of sizes likely mimics in vivo cartilage lesions on the patellar surface.
Despite these limitations, we demonstrated that arthroscopic evaluation of articular cartilage lesions in the knee consistently undersizes lesions, with variable reliability based on lesion size and location. More accurate methods are needed to determine the size of articular cartilage lesions, whether developing new arthroscopic instruments or augmenting existing ones. Until better options are available, decisions regarding the clinical treatment of lesions, as well as studies of treatments for articular cartilage lesions, should reflect this reality.
